The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infectious Diseases Diagnostic Market Research Report 2024
Synopsis
Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.
The global Infectious Diseases Diagnostic market was valued at US$ 16500 million in 2023 and is anticipated to reach US$ 21090 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Diseases Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases Diagnostic.
Report Scope
The Infectious Diseases Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Diseases Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Diseases Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson & Company
Cepheid, Inc.
Abbott Laboratories
bioMerieux SA
Hologic, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Alera Inc.
DiaSorin S.p.A.
Quidel Corporation
Bio-Rad Laboratories, Inc.
Segment by Type
Urine
Blood
Others
Segment by Application
Hospitals and Trauma Centers
Diagnostic Laboratories
Rehabilitation Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.
The global Infectious Diseases Diagnostic market was valued at US$ 16500 million in 2023 and is anticipated to reach US$ 21090 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Diseases Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Diseases Diagnostic.
Report Scope
The Infectious Diseases Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Diseases Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Diseases Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson & Company
Cepheid, Inc.
Abbott Laboratories
bioMerieux SA
Hologic, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Alera Inc.
DiaSorin S.p.A.
Quidel Corporation
Bio-Rad Laboratories, Inc.
Segment by Type
Urine
Blood
Others
Segment by Application
Hospitals and Trauma Centers
Diagnostic Laboratories
Rehabilitation Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Urine
1.2.3 Blood
1.2.4 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Trauma Centers
1.3.3 Diagnostic Laboratories
1.3.4 Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Diseases Diagnostic Market Perspective (2019-2030)
2.2 Infectious Diseases Diagnostic Growth Trends by Region
2.2.1 Global Infectious Diseases Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Diseases Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Infectious Diseases Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Infectious Diseases Diagnostic Market Dynamics
2.3.1 Infectious Diseases Diagnostic Industry Trends
2.3.2 Infectious Diseases Diagnostic Market Drivers
2.3.3 Infectious Diseases Diagnostic Market Challenges
2.3.4 Infectious Diseases Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases Diagnostic Players by Revenue
3.1.1 Global Top Infectious Diseases Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Infectious Diseases Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Diseases Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Diseases Diagnostic Revenue
3.4 Global Infectious Diseases Diagnostic Market Concentration Ratio
3.4.1 Global Infectious Diseases Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Diagnostic Revenue in 2023
3.5 Infectious Diseases Diagnostic Key Players Head office and Area Served
3.6 Key Players Infectious Diseases Diagnostic Product Solution and Service
3.7 Date of Enter into Infectious Diseases Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Diseases Diagnostic Breakdown Data by Type
4.1 Global Infectious Diseases Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Type (2025-2030)
5 Infectious Diseases Diagnostic Breakdown Data by Application
5.1 Global Infectious Diseases Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Diseases Diagnostic Market Size (2019-2030)
6.2 North America Infectious Diseases Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Diseases Diagnostic Market Size by Country (2019-2024)
6.4 North America Infectious Diseases Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Diseases Diagnostic Market Size (2019-2030)
7.2 Europe Infectious Diseases Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Diseases Diagnostic Market Size by Country (2019-2024)
7.4 Europe Infectious Diseases Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Infectious Diseases Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Diseases Diagnostic Market Size (2019-2030)
9.2 Latin America Infectious Diseases Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Diseases Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Infectious Diseases Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Infectious Diseases Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Company Detail
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Infectious Diseases Diagnostic Introduction
11.1.4 Becton Dickinson & Company Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.1.5 Becton Dickinson & Company Recent Development
11.2 Cepheid, Inc.
11.2.1 Cepheid, Inc. Company Detail
11.2.2 Cepheid, Inc. Business Overview
11.2.3 Cepheid, Inc. Infectious Diseases Diagnostic Introduction
11.2.4 Cepheid, Inc. Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.2.5 Cepheid, Inc. Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Infectious Diseases Diagnostic Introduction
11.3.4 Abbott Laboratories Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 bioMerieux SA
11.4.1 bioMerieux SA Company Detail
11.4.2 bioMerieux SA Business Overview
11.4.3 bioMerieux SA Infectious Diseases Diagnostic Introduction
11.4.4 bioMerieux SA Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.4.5 bioMerieux SA Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Detail
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Infectious Diseases Diagnostic Introduction
11.5.4 Hologic, Inc. Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.5.5 Hologic, Inc. Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Detail
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Infectious Diseases Diagnostic Introduction
11.6.4 Danaher Corporation Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.6.5 Danaher Corporation Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Detail
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Detail
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics Infectious Diseases Diagnostic Introduction
11.8.4 Roche Diagnostics Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.8.5 Roche Diagnostics Recent Development
11.9 Alera Inc.
11.9.1 Alera Inc. Company Detail
11.9.2 Alera Inc. Business Overview
11.9.3 Alera Inc. Infectious Diseases Diagnostic Introduction
11.9.4 Alera Inc. Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.9.5 Alera Inc. Recent Development
11.10 DiaSorin S.p.A.
11.10.1 DiaSorin S.p.A. Company Detail
11.10.2 DiaSorin S.p.A. Business Overview
11.10.3 DiaSorin S.p.A. Infectious Diseases Diagnostic Introduction
11.10.4 DiaSorin S.p.A. Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.10.5 DiaSorin S.p.A. Recent Development
11.11 Quidel Corporation
11.11.1 Quidel Corporation Company Detail
11.11.2 Quidel Corporation Business Overview
11.11.3 Quidel Corporation Infectious Diseases Diagnostic Introduction
11.11.4 Quidel Corporation Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.11.5 Quidel Corporation Recent Development
11.12 Bio-Rad Laboratories, Inc.
11.12.1 Bio-Rad Laboratories, Inc. Company Detail
11.12.2 Bio-Rad Laboratories, Inc. Business Overview
11.12.3 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Introduction
11.12.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Diseases Diagnostic Business (2019-2024)
11.12.5 Bio-Rad Laboratories, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
